Form 4: Merck Director Seidman Reports Acquisition of Phantom Stock Units

Christine E. Seidman, a director at Merck & Co., Inc., reported the acquisition of phantom stock units settled in cash, according to a recent SEC Form 4 filing.

Summary

• On March 31, 2025, Christine E. Seidman, a director of Merck & Co., Inc., acquired phantom stock units.
• The transaction involved the acquisition of 90.5192 phantom stock units at a price of $89.76 per unit.
• These phantom stock units are to be settled 100% in cash upon the reporting person's termination of service, following a distribution schedule elected under the Plan for Deferred Payment of Directors' Compensation.
• Seidman directly owns 15,377.6146 shares of Merck common stock, including shares acquired through dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a transaction in phantom stock units. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, according to a pre-determined distribution schedule.

Industry Context

This filing is a routine disclosure of a director's holdings and transactions in company stock, which is common practice for publicly traded companies.

Key Dates

Keywords

Form 4, Merck, Director, Phantom Stock, Beneficial Ownership, Seidman, MRK